Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 26, Pages 15182-15192
Publisher
Proceedings of the National Academy of Sciences
Online
2020-06-18
DOI
10.1073/pnas.1922072117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs
- (2018) Elimelech Nesher et al. CANCER RESEARCH
- Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy
- (2017) Jop C. Teepen et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Pluripotent Stem Cell Differentiation into Functional Epicardial Progenitor Cells
- (2017) Juan Antonio Guadix et al. Stem Cell Reports
- MUSCLEMOTION
- (2017) Luca Sala et al. CIRCULATION RESEARCH
- New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
- (2016) Alberto A. Gabizon et al. DRUG RESISTANCE UPDATES
- Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study
- (2016) Tara O. Henderson et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry
- (2015) Erik Hulegårdh et al. AMERICAN JOURNAL OF HEMATOLOGY
- Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemia
- (2015) Qi Qu et al. LEUKEMIA RESEARCH
- Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia
- (2015) Limin Liu et al. LEUKEMIA RESEARCH
- Chemical profiling of the genome with anti-cancer drugs defines target specificities
- (2015) Baoxu Pang et al. Nature Chemical Biology
- Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors
- (2015) Elżbieta Sadurska PEDIATRIC CARDIOLOGY
- Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
- (2014) Terrence N. Wong et al. NATURE
- Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up
- (2014) Olga Lenčová-Popelová et al. PLoS One
- Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
- (2013) Marzia Lotrionte et al. AMERICAN JOURNAL OF CARDIOLOGY
- Doxorubicin Enhances Nucleosome Turnover around Promoters
- (2013) Fan Yang et al. CURRENT BIOLOGY
- Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts
- (2013) Sheng Zhao et al. Journal of Cardiology
- Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial
- (2013) Jie Jin et al. LANCET ONCOLOGY
- Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
- (2013) Baoxu Pang et al. Nature Communications
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome
- (2011) Guoqing Wei et al. Journal of Hematology & Oncology
- Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper
- (2010) M. Aapro et al. ANNALS OF ONCOLOGY
- The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
- (2010) S. Kayser et al. BLOOD
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Doxorubicin Cardiomyopathy
- (2009) Kanu Chatterjee et al. CARDIOLOGY
- A robust xenotransplantation model for acute myeloid leukemia
- (2009) P V Sanchez et al. LEUKEMIA
- Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies
- (2008) D. Rayson et al. ANNALS OF ONCOLOGY
- Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase beta
- (2008) Sari Neijenhuis et al. DNA REPAIR
- Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy
- (2008) Elke Martin et al. TOXICOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started